Published in Ann Neurol on April 01, 1992
Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr (1997) 2.54
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet (1992) 1.94
Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am J Hum Genet (2000) 1.89
Heteroplasmic point mutations in the human mtDNA control region. Am J Hum Genet (1996) 1.78
Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet (2000) 1.71
A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. Am J Hum Genet (1994) 1.39
Mitochondria. J Neurol Neurosurg Psychiatry (2003) 1.36
Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation. J Med Genet (2006) 1.34
Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J Mol Diagn (2003) 1.32
Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model. Proc Natl Acad Sci U S A (2013) 1.28
Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet (1994) 1.26
A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am J Hum Genet (1999) 1.20
Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am J Hum Genet (1996) 1.13
UK centres are not following the Royal College of Pathologists' recommendations for storage of Guthrie cards: a national policy is needed. J Med Genet (1998) 1.10
Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer? Hum Reprod (2013) 1.07
Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc Natl Acad Sci U S A (1995) 1.04
Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology (2011) 1.02
Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol (1995) 1.00
Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet (1995) 0.95
Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene. Arch Dis Child (2000) 0.93
31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol (2007) 0.92
MELAS syndrome with mitochondrial tRNA(Leu(UUR)) gene mutation in a Chinese family. J Neurol Neurosurg Psychiatry (1994) 0.91
Mitochondrial DNA disease and developmental implications for reproductive strategies. Mol Hum Reprod (2014) 0.90
Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development. J Med Genet (2006) 0.88
Sequence analysis of mitochondrial DNA in a new maternally inherited encephalomyopathy. J Neurol (1995) 0.87
What cost mitochondria? The maintenance of functional mitochondrial DNA within and across generations. Philos Trans R Soc Lond B Biol Sci (2014) 0.87
Mitochondrial disorders with significant ophthalmic manifestations. Middle East Afr J Ophthalmol (2008) 0.86
Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient. Rev Endocr Metab Disord (2006) 0.85
Identification and management of difficult stroke and TIA syndromes. J Neurol Neurosurg Psychiatry (2001) 0.84
Auditory function in individuals within Leber's hereditary optic neuropathy pedigrees. J Neurol (2011) 0.84
MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry (1998) 0.84
Heteroplasmy and organelle gene dynamics. Genetics (1998) 0.83
The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome. J Neurol Neurosurg Psychiatry (1996) 0.83
A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions. Nucleic Acids Res (2015) 0.80
Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation. Biochem J (2005) 0.78
Two unusual clinical presentations of the mitochondrial DNA A3243G point mutation in adult neurological practice. J Neurol Neurosurg Psychiatry (1997) 0.77
Epidemiology and characteristics of occipital brain infarcts in young adults in southwestern Finland. J Neurol (2010) 0.77
Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck. Hum Mol Genet (2016) 0.76
MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev (2016) 0.75
Wolff-Parkinson-white syndrome in a patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes syndrome. Korean Circ J (2011) 0.75
The investigation of mitochondrial respiratory chain disease. J R Soc Med (1995) 0.75
Migratory stroke-like lesions in a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and a review of imaging findings. Radiol Case Rep (2016) 0.75
Speech-Language and swallowing manifestations and rehabilitation in an 11-year-old girl with MELAS syndrome. J Pediatr Neurosci (2015) 0.75
MELAS syndrome. West J Med (1995) 0.75
Importance of Distinguishing Between Mitochondrial Encephalomyopathy With Elderly Onset of Stroke-Like Episodes and Cerebral Infarction. J Clin Med Res (2017) 0.75
Mitochondrial genotype and clinical phenotype. J Inherit Metab Dis (1998) 0.75
Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the Drosophila Barren protein. Cell (1997) 5.86
Identification of Xenopus SMC protein complexes required for sister chromatid cohesion. Genes Dev (1998) 5.78
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature (2000) 5.71
Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet (2001) 4.54
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. Kidney Int (2000) 4.43
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology (1988) 4.28
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology (2006) 4.11
Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science (1999) 4.05
Phosphorylation and activation of 13S condensin by Cdc2 in vitro. Science (1998) 3.89
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A (2001) 3.54
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology (2010) 3.37
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) (2004) 3.07
A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science (1989) 3.02
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet (2005) 2.92
MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci U S A (1992) 2.82
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79
Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. Am J Hum Genet (1990) 2.77
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet (1998) 2.72
Morphological structure of the vocal cord as a vibrator and its variations. Folia Phoniatr (Basel) (1974) 2.62
Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet (1999) 2.59
Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye (Lond) (2006) 2.56
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet (1991) 2.53
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta (2004) 2.52
Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40
The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid (2009) 2.35
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science (1973) 2.34
Fingerprint body myopathy, a newly recognized congenital muscle disease. Mayo Clin Proc (1972) 2.34
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res (1990) 2.28
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res (2000) 2.26
Cytochrome c oxidase assembly in primates is sensitive to small evolutionary variations in amino acid sequence. Mol Biol Evol (2000) 2.19
Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A (2000) 2.19
Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet (1991) 2.10
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell (1995) 2.06
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun (1995) 2.06
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology (1994) 2.00
Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods (2003) 1.99
Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98
'Outbreak' of optic and peripheral neuropathy in Cuba? JAMA (1993) 1.97
Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology (1990) 1.97
An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol (2000) 1.95
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet (1992) 1.94
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem (1999) 1.92
The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol (1994) 1.91
Potential contribution of consumers to an integrated health care system. Public Health Rep (1976) 1.90
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology (2005) 1.90
Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy (2000) 1.90
Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet (1995) 1.89
Analyis of met-form haemoglobins in human erythrocytes of normal adults and of a patient with hereditary methaemoglobinaemia due to deficiency of NADH-cytochrome b5 reductase. Biochem J (1979) 1.88
p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene (2011) 1.86
Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2000) 1.84
Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope. Biophys J (2000) 1.83
Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology (2004) 1.83
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol (2000) 1.82
Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med (1997) 1.82
Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia (1997) 1.82
Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology (1989) 1.81
Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology (2005) 1.80
Low-cost improvements in prehospital trauma care in a Latin American city. J Trauma (2000) 1.80
Mitochondrial encephalomyopathies. Arch Neurol (1993) 1.79
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci (1992) 1.79
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology (2001) 1.75
Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve (2004) 1.73
Cerebellar ataxia and coenzyme Q10 deficiency. Neurology (2003) 1.73
Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol (1988) 1.73
Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology (1999) 1.72
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology (2001) 1.68
Videostroboscopic evaluation of the larynx. Ear Nose Throat J (1987) 1.64
GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology (2000) 1.64
Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet (1995) 1.63
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology (1995) 1.62
Initiation of meiosis and sporulation in Saccharomyces cerevisiae requires a novel protein kinase homologue. Mol Gen Genet (1990) 1.60
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril (1989) 1.60
Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia (2009) 1.60